An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen Health

Tirzepatide in Atlanta: clinics and prices

Atlanta patients can get brand tirzepatide as Zepbound for weight or Mounjaro for type 2 diabetes; Zepbound self-pay through LillyDirect is $299 for 2.5 mg up to $449 for higher doses refilled within 45 days, as of Oct 17 2026 [1]. A prescription is required.

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Tirzepatide is a weekly injectable that activates both GIP and GLP-1 receptors, sold as Zepbound and Mounjaro.

Zepbound cash price
$299 / $399 / $449 by dose, Oct 17 2026 [1]
Diagnosed diabetes, Atlanta
10.6% city, 10.9% Fulton County [2][3]
Georgia Medicaid
Not listed as covering obesity GLP-1s (KFF, Jan 2026) [4]
Prescriber licensing
Georgia Composite Medical Board [5]

See tirzepatide prices

Diabetes or weight: two different paths in Georgia

Roughly one in ten Atlanta adults (10.6%) reports diagnosed diabetes [2]. For them, Mounjaro is the tirzepatide product labeled for blood sugar control in type 2 diabetes [6], and insurance coverage is more common. People without diabetes who want tirzepatide for weight are prescribed Zepbound [7], and Georgia Medicaid does not pay for that use [4].

Sponsored content sits in a labeled box. It is advertising, not a vote of confidence from us.

Self-pay math for Zepbound

LillyDirect self-pay, checked Oct 17 2026
DosePrice per monthConditionSource
2.5 mg (starting dose)$299None[1]
5 mg$399None[1]
7.5 to 15 mg$449Refill within 45 days[1]
7.5 mg / 10 to 15 mg$499 / $699Outside the 45-day window[1]
The label calls for starting at 2.5 mg for 4 weeks and raising the dose in 2.5 mg steps after at least 4 weeks [7], so cost rises over the first months. See tirzepatide cost.

At $449 a month, a full year on a maintenance dose comes to $5,388 before any visit fees. Lilly's savings card can cut the price to as little as $25 for commercially insured patients whose plan covers Zepbound [8].

Results and limits from the trials

In SURMOUNT-1, the average weight loss at 72 weeks was 15.0%, 19.5% and 20.9% on the 5, 10 and 15 mg doses, versus 3.1% on placebo [9]. In a head-to-head trial, SURMOUNT-5, people on tirzepatide lost 20.2% on average at 72 weeks versus 13.7% on semaglutide [10]. Averages do not predict any one person's result. More on tirzepatide results and Wegovy vs Zepbound.

Before you sign up with a local clinic

  • Confirm the prescriber on the Georgia Composite Medical Board site [5].
  • Ask whether you will get Zepbound or a compounded product. Compounded tirzepatide is not FDA-approved [11]; see compounded tirzepatide.
  • Ask what the monthly fee covers beyond the drug: visits, labs, needles.
  • Check the online options in our tirzepatide online guide for comparison.

Label safety points

Boxed warning for thyroid C-cell tumors; do not use with a personal or family history of medullary thyroid carcinoma or MEN 2. Stop and call your prescriber for severe, persistent stomach pain. Risk of low blood sugar rises with insulin or a sulfonylurea. Zepbound may cause fetal harm; stop it when pregnancy is recognized [12].

Other tirzepatide city guides: Nashville, Tampa, Orlando, New York City. Start from the tirzepatide guide or the tirzepatide near me checklist.

Questions people ask

How much is Zepbound in Atlanta without insurance?

LillyDirect charges $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5 to 15 mg when refilled within 45 days, as of Oct 17 2026 [1].

Does Georgia Medicaid cover tirzepatide for weight loss?

Georgia was not on KFF's January 2026 list of 13 Medicaid programs covering GLP-1s for obesity [4].

Is Mounjaro the same as Zepbound?

Both contain tirzepatide. Mounjaro is approved for type 2 diabetes [6], and Zepbound for weight management and obstructive sleep apnea with obesity [7].

How much weight do people lose on tirzepatide?

In SURMOUNT-1, adults on the 15 mg dose lost an average of 20.9% of body weight at 72 weeks, compared with 3.1% on placebo [9].

Is tirzepatide better than semaglutide?

In SURMOUNT-5, average weight loss at 72 weeks was 20.2% with tirzepatide versus 13.7% with semaglutide [10]. Side effects, cost and coverage also matter.

How do I verify an Atlanta tirzepatide prescriber?

Look the person up on the Georgia Composite Medical Board website, which licenses physicians in Georgia [5].

Sources

12 cited
  1. Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  2. PLACES: Place Data, Atlanta (2025 release, BRFSS 2023). CDC, 2023.
  3. PLACES: County Data, Fulton County, GA (2025 release, BRFSS 2023). CDC, 2023.
  4. Medicaid Coverage of and Spending on GLP-1s. KFF, Jan 16, 2026.
  5. Georgia Composite Medical Board. State of Georgia, Oct 17, 2026.
  6. Mounjaro label. DailyMed, National Library of Medicine, Aug 2026.
  7. Zepbound label. DailyMed, National Library of Medicine, Aug 2026.
  8. Zepbound coverage and savings. Eli Lilly and Company, Oct 17, 2026.
  9. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), Jun 4, 2022.
  10. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine (PubMed), May 11, 2025.
  11. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  12. Zepbound prescribing information (217806s050). U.S. Food and Drug Administration, Apr 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See tirzepatide prices